RSS-Feed abonnieren
DOI: 10.1055/s-0040-1705061
ENDOSCOPIC INTERNAL DRAINAGE VS. LOW NEGATIVE PRESSURE ENDOLUMINAL VACUUM THERAPY FOR LEAKAGES AFTER ONCOLOGIC UPPER GASTROINTESTINAL SURGERY
Publikationsverlauf
Publikationsdatum:
23. April 2020 (online)
Aims Endoscopic internal drainage using pigtail stents (EID) serves as treatment option for leakages after upper GI oncologic surgery. Endoluminal vacuum therapy (EVT) also offers high closure rates and active therapy surveillance. Secretion drainage and mucosal irrigation are mechanisms of action. Both treatments have not been compared in larger studies.
Methods Between 2016 and 2019, patients treated for postoperative leakages after oncologic upper GI surgery at five reference centers for digestive endoscopy in France(group A) and Göttingen (group B) were included. General patient- and procedure related data were retrospectively analyzed and compared using propensity score matching. Group A was treated with EID, group B received low negative pressure EVT (−20/-50 mmHg). Pigtails were changed every 4 weeks, whereas EVT was repeated every 3–4 days. Besides descriptive analysis, comparison was performed using Fishers exact test and Poisson regression test.
Results A total of 35 (A) and 27 (B) patients where included. Age (62 ± 8.8y A vs. 66 ± 10y B), Charlson Morbidity score (4 ± 1.1 A vs. 5 ± 2.1 B) and diagnosis after surgery (12 ± 9.8d A vs. 8 ± 8.5d B) were equal in both groups. Type of surgery was Ivor Lewis Esophagectomy in 48.6% (A) and 70.4% (B). Leakage sizes ranged from 5 mm to over 2 cm. Treatment success was higher in group A (n = 35/35) than in group B (23/27; p = 0.03). Less endoscopies were necessary for leak closure in group A when compared to group B (n = 2.5 ± 0.66 A vs. 4.1 ± 3 B; p = 0.008). Esophageal stenoses during follow-up were less frequent after EID (n = 3/35 A) vs. EVT (n = 4/27; p = 0.05).
Conclusions In this propensity score matched study, EID provides better healing rates and long-term outcome than low negative pressure EVT. EID presents a cost-effective alternative in patients with leakages after oncologic upper GI surgery. Larger studies are needed to confirm these primary results.
#